NASDAQ:OPGN - OpGen News Headlines

$0.33
-0.02 (-5.71 %)
(As of 07/16/2019 04:00 PM ET)
Today's Range
$0.32
Now: $0.33
$0.35
50-Day Range
$0.35
MA: $0.41
$0.52
52-Week Range
$0.32
Now: $0.33
$2.41
Volume178,400 shs
Average Volume367,881 shs
Market Capitalization$5.82 million
P/E RatioN/A
Dividend YieldN/A
Beta0.84

Headlines

OpGen (NASDAQ OPGN) News Headlines

Source:
DateHeadline
Short Interest in OpGen Inc (NASDAQ:OPGN) Expands By 37.2%Short Interest in OpGen Inc (NASDAQ:OPGN) Expands By 37.2%
www.americanbankingnews.com - July 12 at 9:05 AM
OpGen up 5% on positive Acuitas Gene Panel dataOpGen up 5% on positive Acuitas Gene Panel data
seekingalpha.com - June 29 at 8:17 AM
OpGens Acuitas® AMR Gene Panel Shows Potential for Reducing Total Time to Targeted Therapy - GlobeNewswireOpGen's Acuitas® AMR Gene Panel Shows Potential for Reducing Total Time to Targeted Therapy - GlobeNewswire
globenewswire.com - June 27 at 8:29 AM
OpGen’s Acuitas® AMR Gene Panel Shows Potential for Reducing Total Time to Targeted TherapyOpGen’s Acuitas® AMR Gene Panel Shows Potential for Reducing Total Time to Targeted Therapy
finance.yahoo.com - June 27 at 8:28 AM
Short Interest in OpGen Inc (NASDAQ:OPGN) Decreases By 34.9%Short Interest in OpGen Inc (NASDAQ:OPGN) Decreases By 34.9%
www.americanbankingnews.com - June 26 at 11:31 PM
OpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak Detection - Yahoo FinanceOpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak Detection - Yahoo Finance
finance.yahoo.com - June 15 at 6:29 PM
A Look At Benzinga Pros Most-Searched Tickers For June 14 - Yahoo FinanceA Look At Benzinga Pro's Most-Searched Tickers For June 14 - Yahoo Finance
finance.yahoo.com - June 15 at 12:42 AM
Mid-Afternoon Market Update: Dow Rises 80 Points; Red Robin Shares Spike Higher - NasdaqMid-Afternoon Market Update: Dow Rises 80 Points; Red Robin Shares Spike Higher - Nasdaq
www.nasdaq.com - June 13 at 7:42 PM
OpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak Detection - NasdaqOpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak Detection - Nasdaq
www.nasdaq.com - June 13 at 7:42 PM
OpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak Detection - GlobeNewswireOpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak Detection - GlobeNewswire
globenewswire.com - June 13 at 12:53 PM
OpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak DetectionOpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak Detection
finance.yahoo.com - June 13 at 12:53 PM
Antibiotic Resistance Market, 2023 with Profiles of 100+ Biotechnology Companies - GlobeNewswireAntibiotic Resistance Market, 2023 with Profiles of 100+ Biotechnology Companies - GlobeNewswire
www.globenewswire.com - June 10 at 8:26 AM
OpGen Reports First Quarter 2019 Financial Results and Provides Business Update - Yahoo FinanceOpGen Reports First Quarter 2019 Financial Results and Provides Business Update - Yahoo Finance
finance.yahoo.com - May 15 at 8:26 AM
Edited Transcript of OPGN earnings conference call or presentation 14-May-19 8:30pm GMTEdited Transcript of OPGN earnings conference call or presentation 14-May-19 8:30pm GMT
finance.yahoo.com - May 15 at 8:26 AM
OpGen Reports First Quarter 2019 Financial Results and Provides Business Update - NasdaqOpGen Reports First Quarter 2019 Financial Results and Provides Business Update - Nasdaq
www.nasdaq.com - May 14 at 8:04 PM
OpGen, Inc. (OPGN) Reports Q1 Loss, Misses Revenue Estimates - NasdaqOpGen, Inc. (OPGN) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq
www.nasdaq.com - May 14 at 8:04 PM
OpGen Reports First Quarter 2019 Financial Results and Provides Business UpdateOpGen Reports First Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - May 14 at 8:04 PM
OpGen, Inc. (OPGN) Reports Q1 Loss, Misses Revenue EstimatesOpGen, Inc. (OPGN) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 14 at 8:04 PM
U.S. STOCKS ON THE MOVE-Uber, Solid Biosciences, Boeing, Shopify - NasdaqU.S. STOCKS ON THE MOVE-Uber, Solid Biosciences, Boeing, Shopify - Nasdaq
www.nasdaq.com - May 14 at 8:36 AM
OpGen (OPGN) Reports Filing of Initial FDA 510(k) Submission for Acuitas AMR Gene Panel Test to Identify Presence of Antibiotic Resistance - StreetInsider.comOpGen (OPGN) Reports Filing of Initial FDA 510(k) Submission for Acuitas AMR Gene Panel Test to Identify Presence of Antibiotic Resistance - StreetInsider.com
www.streetinsider.com - May 14 at 8:36 AM
OpGen Completes Initial FDA 510(k) Submission for its Acuitas® AMR Gene Panel Test to Identify Presence of Antibiotic ResistanceOpGen Completes Initial FDA 510(k) Submission for its Acuitas® AMR Gene Panel Test to Identify Presence of Antibiotic Resistance
finance.yahoo.com - May 14 at 8:36 AM
Will OpGen, Inc. (OPGN) Report Negative Q1 Earnings? What You Should Know - Yahoo FinanceWill OpGen, Inc. (OPGN) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance
finance.yahoo.com - May 7 at 7:04 PM
Will OpGen, Inc. (OPGN) Report Negative Q1 Earnings? What You Should KnowWill OpGen, Inc. (OPGN) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - May 7 at 7:04 PM
OpGen Announces Date of First Quarter 2019 Financial Results Conference Call - GlobeNewswireOpGen Announces Date of First Quarter 2019 Financial Results Conference Call - GlobeNewswire
globenewswire.com - May 7 at 8:21 AM
Teladocs Partnership to Form Pediatric Telehealth Platform - NasdaqTeladoc's Partnership to Form Pediatric Telehealth Platform - Nasdaq
www.nasdaq.com - April 12 at 8:39 PM
OpGen Announces Closing of Public Offering of Common Stock - GlobeNewswireOpGen Announces Closing of Public Offering of Common Stock - GlobeNewswire
globenewswire.com - March 30 at 7:21 PM
OpGen Announces Closing of Public Offering of Common Stock - NasdaqOpGen Announces Closing of Public Offering of Common Stock - Nasdaq
www.nasdaq.com - March 29 at 7:42 PM
OpGen Announces Closing of Public Offering of Common StockOpGen Announces Closing of Public Offering of Common Stock
finance.yahoo.com - March 29 at 7:42 PM
OpGen Data Predicting Antibiotic Resistance Published in Antimicrobial Agents and Chemotherapy Journal - GlobeNewswireOpGen Data Predicting Antibiotic Resistance Published in Antimicrobial Agents and Chemotherapy Journal - GlobeNewswire
globenewswire.com - March 29 at 8:22 AM
OpGen Data Predicting Antibiotic Resistance Published in Antimicrobial Agents and Chemotherapy Journal - NasdaqOpGen Data Predicting Antibiotic Resistance Published in Antimicrobial Agents and Chemotherapy Journal - Nasdaq
www.nasdaq.com - March 28 at 8:23 AM
OpGen Data Predicting Antibiotic Resistance Published in Antimicrobial Agents and Chemotherapy JournalOpGen Data Predicting Antibiotic Resistance Published in Antimicrobial Agents and Chemotherapy Journal
finance.yahoo.com - March 28 at 8:23 AM
OpGen Announces Pricing of a $5.4 Million Public Offering of Common Stock - GlobeNewswireOpGen Announces Pricing of a $5.4 Million Public Offering of Common Stock - GlobeNewswire
globenewswire.com - March 27 at 8:21 AM
OpGen (OPGN) Prices 9M Share Common Offering at $0.60/Sh - StreetInsider.comOpGen (OPGN) Prices 9M Share Common Offering at $0.60/Sh - StreetInsider.com
www.streetinsider.com - March 26 at 7:48 PM
OpGen Announces Pricing of a $5.4 Million Public Offering of Common StockOpGen Announces Pricing of a $5.4 Million Public Offering of Common Stock
finance.yahoo.com - March 26 at 7:48 PM
U.S. STOCKS ON THE MOVE-Weatherford, Inphi, Opgen, ZTO, Bed Bath & Beyond - NasdaqU.S. STOCKS ON THE MOVE-Weatherford, Inphi, Opgen, ZTO, Bed Bath & Beyond - Nasdaq
www.nasdaq.com - March 26 at 8:23 AM
OpGen and Mercks ILÚM Health Solutions to Host Event at VIII International Symposium on Hospital Acquired Infections and Antimicrobial Stewardship - GlobeNewswireOpGen and Merck's ILÚM Health Solutions to Host Event at VIII International Symposium on Hospital Acquired Infections and Antimicrobial Stewardship - GlobeNewswire
www.globenewswire.com - March 25 at 9:01 AM
OpGen and Merck’s ILÚM Health Solutions to Host Event at VIII International Symposium on Hospital Acquired Infections and Antimicrobial StewardshipOpGen and Merck’s ILÚM Health Solutions to Host Event at VIII International Symposium on Hospital Acquired Infections and Antimicrobial Stewardship
finance.yahoo.com - March 25 at 9:01 AM
OpGen, Inc. Estimate MomentumOpGen, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 8:05 PM
OpGen IncOpGen Inc
www.bloomberg.com - March 18 at 8:05 PM
OpGen, Inc. (OPGN) CEO Evan Jones on Q4 2018 Results - Earnings Call TranscriptOpGen, Inc. (OPGN) CEO Evan Jones on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - February 27 at 8:16 AM
Edited Transcript of OPGN earnings conference call or presentation 26-Feb-19 9:30pm GMTEdited Transcript of OPGN earnings conference call or presentation 26-Feb-19 9:30pm GMT
finance.yahoo.com - February 27 at 8:16 AM
OpGen Reports Fourth Quarter and 2018 Financial Results and Provides Business UpdateOpGen Reports Fourth Quarter and 2018 Financial Results and Provides Business Update
finance.yahoo.com - February 26 at 6:46 PM
OpGen Appoints R. Don Elsey to Board of DirectorsOpGen Appoints R. Don Elsey to Board of Directors
finance.yahoo.com - February 25 at 7:07 PM
OpGen Announces Date of Fourth Quarter and Fiscal Year 2018 Financial Results Conference CallOpGen Announces Date of Fourth Quarter and Fiscal Year 2018 Financial Results Conference Call
finance.yahoo.com - February 20 at 6:54 PM
OpGen completes studies to support Acuitas gene panel filing; shares up 4%OpGen completes studies to support Acuitas gene panel filing; shares up 4%
seekingalpha.com - February 5 at 6:35 PM
OpGen Completes Clinical Trials for its Initial FDA 510(k) SubmissionOpGen Completes Clinical Trials for its Initial FDA 510(k) Submission
finance.yahoo.com - February 5 at 6:35 PM
OpGen Completes CDC Contract to Develop Clinical Support Mobile-Based Tools for Antimicrobial Stewardship and Infection Control - GlobeNewswireOpGen Completes CDC Contract to Develop Clinical Support Mobile-Based Tools for Antimicrobial Stewardship and Infection Control - GlobeNewswire
globenewswire.com - December 19 at 5:54 PM
OpGen Completes CDC Contract to Develop Clinical Support Mobile-Based Tools for Antimicrobial Stewardship and Infection ControlOpGen Completes CDC Contract to Develop Clinical Support Mobile-Based Tools for Antimicrobial Stewardship and Infection Control
finance.yahoo.com - December 18 at 8:14 AM
OpGen (OPGN) Announces Regulatory Approval to Market Pathogen Identification Products in ColombiaOpGen (OPGN) Announces Regulatory Approval to Market Pathogen Identification Products in Colombia
www.streetinsider.com - December 5 at 5:20 PM
OpGen Receives Regulatory Approval to Market Pathogen Identification Products in Colombia - GlobeNewswireOpGen Receives Regulatory Approval to Market Pathogen Identification Products in Colombia - GlobeNewswire
globenewswire.com - December 4 at 5:41 PM
This page was last updated on 7/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel